ArticleCancer science2019

Cancer therapy with major histocompatibility complex-deficient and interferon β-producing myeloid cells derived from allogeneic embryonic stem cells.

Satoshi Umemoto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.